These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 11556261)

  • 21. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
    Kondagunta GV; Bacik J; Donadio A; Bajorin D; Marion S; Sheinfeld J; Bosl GJ; Motzer RJ
    J Clin Oncol; 2005 Sep; 23(27):6549-55. PubMed ID: 16170162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical study on poor-risk patients with non-seminomatous germ cell tumor].
    Okamura K; Takashi M; Hibi H; Tsuji Y; Shimoji T; Ohshima S; Takagi Y; Suzuki Y; Mizutani K; Ono Y; Kato T; Kobayashi M
    Hinyokika Kiyo; 1998 Apr; 44(4):265-72. PubMed ID: 9617623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors.
    Eggener SE; Carver BS; Loeb S; Kondagunta GV; Bosl GJ; Sheinfeld J
    Cancer; 2007 Feb; 109(3):528-35. PubMed ID: 17177200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The management of patients with advanced germ cell tumors. Seminoma and nonseminoma.
    Law TM; Motzer RJ; Bajorin DF; Bosl GJ
    Urol Clin North Am; 1994 Nov; 21(4):773-83. PubMed ID: 7974906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of patients with stage I nonseminomal germ cell testicular tumors].
    Arutiunian NO; Figurin KM; Shabanov MA; Tiuliandin SA
    Urol Nefrol (Mosk); 1999; (2):39-42. PubMed ID: 12434442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two cycles of carboplatin-based adjuvant chemotherapy for high-risk clinical stage I and stage IM non-seminomatous germ cell tumours of the testis: a HECOG trial.
    Pectasides D; Skarlos D; Dimopoulos AM; Farmakis D; Pectasides M; Fountzilas G; Aravantinos G
    Anticancer Res; 2003; 23(5b):4239-44. PubMed ID: 14666633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
    J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
    J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chemotherapy-resistant germ cell cancer of the testis treated by salvage surgery: a case report].
    Taue R; Harada A; Katto K; Yamamoto Y; Kishimoto T; Nakatuji Y; Tanimoto S; Oka N; Izaki H; Fukumori T; Takahashi M; Nishitani M; Kanayama HO
    Hinyokika Kiyo; 2006 Apr; 52(4):293-6. PubMed ID: 16686359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
    Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant chemotherapy for testicular cancer.
    Xiao H; Sheinfeld J; Motzer RJ
    Surg Oncol Clin N Am; 1997 Oct; 6(4):863-78. PubMed ID: 9309098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Survival and quality of life of patients with testicular cancer].
    Lugagne Delpon PM; Petit M; Houlgatte A; Droz JP
    Ann Urol (Paris); 1998; 32(2):80-2. PubMed ID: 9599637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy of disseminated germ cell tumors.
    Nichols CR
    Semin Urol Oncol; 2001 Aug; 19(3):157-64. PubMed ID: 11561982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection.
    Hermans BP; Sweeney CJ; Foster RS; Einhorn LE; Donohue JP
    J Urol; 2000 Jun; 163(6):1721-4. PubMed ID: 10799168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salvage therapy for germ cell tumors.
    Einhorn LH
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):47-51. PubMed ID: 8091241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk adapted management with adjuvant chemotherapy in patients with high risk clinical stage i nonseminomatous germ cell tumor.
    Studer UE; Burkhard FC; Sonntag RW
    J Urol; 2000 Jun; 163(6):1785-7. PubMed ID: 10799182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant chemotherapy for stage II nonseminomatous testicular cancer: what is its role?
    Motzer RJ
    Semin Urol Oncol; 1996 Feb; 14(1):30-3. PubMed ID: 8833386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment outcome on 52 patients with 53 testicular germ cell tumors].
    Yokoyama M; Nemoto K; Kanemura M; Kitahara K; Oda H; Murata H; Matsunaga Y
    Hinyokika Kiyo; 1998 Nov; 44(11):789-94. PubMed ID: 9893223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle.
    Yoon GH; Stein JP; Skinner DG
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):75-85. PubMed ID: 15757440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.